Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer From the Danish “MALOVA” Ovarian Cancer Study-Reference-Cited by-同舟云学术

Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer From the Danish “MALOVA” Ovarian Cancer Study

Published:2007-08 Issue:2 Volume:106 Page:318-324
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Høgdall Estrid V.S.,Christensen Lise,Kjaer Susanne K.,Blaakaer Jan,Christensen Ib Jarle,Gayther Simon,Jacobs Ian J.,Høgdall Claus K.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference26 articles.

1. Trends in the incidence and mortality of ovarian cancer in Denmark 1978–2002 — comparison with other Nordic countries;Kjaerbye-Thygesen;Acta Obstet Gynecol Scand,2005

2. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis;Lu;Clin Cancer Res,2004

3. Biomarkers of ovarian tumours;Rapkiewicz;Eur J Cancer,2004

4. Wilms' tumour gene and function;Hastie;Curr Opin Genet Dev,1993

5. Analysis of the 11p13 Wilms' tumor suppressor gene (WT1) in ovarian tumors;Bruening;Cancer Investig,1993

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcription factors in epithelial ovarian cancer: histotype-specific drivers and novel therapeutic targets;Pharmacology & Therapeutics;2021-04

2. Wilms’ tumor 1 antigen immunoreactivity in epithelial ovarian cancer — diagnostic and prognostic value;Folia Histochemica et Cytobiologica;2020-10-09

3. Wilms’ tumor 1 (WT1) promotes ovarian cancer progression by regulating E-cadherin and ERK1/2 signaling;Cell Cycle;2020-09-07

4. Diagnostic and Prognostic Role of WT1 Immunohistochemical Expression in Uterine Carcinoma: A Systematic Review and Meta-Analysis across All Endometrial Carcinoma Histotypes;Diagnostics;2020-08-26

5. Wilms’ tumor 1 (WT1) as a prognosis factor in gynecological cancers;Medicine;2018-07